Our work is aimed at unraveling the role of the first-phase insulin secretion in the natural
history of type 2 diabetes mellitus (T2DM) and its interrelationship with insulin resistance …

The classic description of diabetic kidney disease (DKD) involves progressive stages of
glomerular hyperfiltration, microalbuminuria, proteinuria, and a decline in the estimated …

Background: The role of statin therapy in the development of kidney disease in patients with
type 2 diabetes mellitus (DM) remains uncertain. We aimed to determine the relationships …

The burden of diabetes continues to increase in South Africa and a significant number of
diabetes patients present at public primary healthcare facilities with uncontrolled glucose …

Intensive glycemic control is insufficient for reducing the risk of heart failure among patients
with diabetes mellitus (DM). While the" hyperglycemic memory" phenomenon is well …

Abstract Aims/Introduction The EMPA‐REG OUTCOME® trial demonstrated benefits of
empagliflozin, a sodium‐glucose cotransporter‐2 inhibitor (SGLT2i), on cardiovascular …

Background We performed a systematic overview of the cost-effectiveness analyses (CEAs)
comparing Non-insulin antidiabetic drugs (NIADs) with other NIADs for the treatment of type …

Introduction The global volume of surgery is growing and the population ageing, and
economic pressure is rising. Major surgery is associated with relevant morbidity and …

Objective Long-term type 2 diabetes management requires open communication between a
patient and their provider for self-care adherence. This study explored facilitators and …

According to the World Health Organization, more than 422 million people worldwide have
diabetes. The most common oral treatment for type 2 diabetes is the drug metformin (MTF) …